Skip to main content
    T

    Tenaya Therapeutics Inc (TNYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.02 (-4.47%)

    Market Cap: $79.59M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tenaya Therapeutics Inc (TNYA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Tenaya Therapeutics are Tenax Therapeutics (TENX), vTv Therapeutics (VTVT) and Coya Therapeutics, Inc. Common Stock (COYA). By market cap, Tenaya Therapeutics ranks 6th of the 13 companies on this page; LENZ Therapeutics (LENZ) is the largest at $129.77M.

    Peer Comparison

    TNYA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Tenaya Therapeutics (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Coya Therapeutics, Inc. Common Stock (COYA)$73.42MN/A15.0x0.0%N/A-93.4%0.00%
    LENZ Therapeutics Inc (LENZ)$129.77MN/A9.7x0.0%N/A-72.9%0.00%
    Rani Therapeutics Holdings Inc (RANI)$60.78MN/A16.3x0.0%N/A893.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Vivani Medical Inc. (VANI)$91.11MN/AN/A0.0%N/A0.0%0.00%
    TuHURA Biosciences Inc (HURA)$88.58MN/AN/A0.0%-81.8%0.0%0.00%
    Voyager Therapeutics Inc (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    Unicycive Therapeutics Inc (UNCY)$97.25MN/AN/A0.0%N/A0.0%0.00%
    Peer median$76.38MN/A12.4x0.0%-126.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Tenaya Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors
    Coya Therapeutics, Inc. Common Stock (COYA)
    Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs).
    COYA competitors
    LENZ Therapeutics Inc (LENZ)
    LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders...
    LENZ competitors
    Rani Therapeutics Holdings Inc (RANI)
    Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology...
    RANI competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Vivani Medical Inc. (VANI)
    Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery...
    VANI competitors
    TuHURA Biosciences Inc (HURA)
    TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases.
    HURA competitors
    Voyager Therapeutics Inc (VYGR)
    Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases.
    VYGR competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    Unicycive Therapeutics Inc (UNCY)
    Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases...
    UNCY competitors

    Frequently Asked Questions About TNYA

    Who are Tenaya Therapeutics' main competitors?

    The companies most similar to Tenaya Therapeutics include Tenax Therapeutics (TENX), vTv Therapeutics (VTVT), Coya Therapeutics, Inc. Common Stock (COYA), LENZ Therapeutics (LENZ) and Rani Therapeutics Holdings (RANI), listed from the closest match.

    Who is Tenaya Therapeutics' biggest competitor?

    LENZ Therapeutics (LENZ) is the largest of the similar companies at $129.77M; Tenax Therapeutics (TENX) is the closest match by business profile, size, sector and industry.

    How does TNYA stock compare with its competitors?

    TNYA's net margin is 0.0% against a peer median of 0.0%.

    Which of Tenaya Therapeutics' competitors pays a higher dividend?

    Tenaya Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Tenaya Therapeutics bigger than its competitors?

    No. Tenaya Therapeutics is 6th by market cap among the 13 companies on this page; the largest is LENZ Therapeutics (LENZ) at $129.77M.